Persistence and emergence of X4 virus in HIV infection

  • Received: 01 March 2010 Accepted: 29 June 2018 Published: 01 April 2011
  • MSC : Primary: 92C37, 92C45; Secondary: 92C50.

  • Approximately 50% of late-stage HIV patients develop CXCR4-tropic (X4) virus in addition to CCR5-tropic (R5) virus. X4 emergence occurs with a sharp decline in CD4+ T cell counts and accelerated time to AIDS. Why this phenotypic switch to X4 occurs is not well understood. Previously, we used numerical simulations of a mathematical model to show that across much of parameter space a promising new class of antiretroviral treatments, CCR5 inhibitors, can accelerate X4 emergence and immunodeficiency. Here, we show that mathematical model to be a minimal activation-based HIV model that produces a spontaneous switch to X4 virus at a clinically-representative time point, while also matching in vivo data showing X4 and R5 coexisting and competing to infect memory CD4+ T cells. Our analysis shows that X4 avoids competitive exclusion from an initially fitter R5 virus due to X4v unique ability to productively infect nave CD4+ T cells. We further justify the generalized conditions under which this minimal model holds, implying that a phenotypic switch can even occur when the fraction of activated nave CD4+ T cells increases at a slower rate than the fraction of activated memory CD4+ T cells. We find that it is the ratio of the fractions of activated nave and memory CD4+ T cells that must increase above a threshold to produce a switch. This occurs as the concentration of CD4+ T cells drops beneath a threshold. Thus, highly active antiretroviral therapy (HAART), which increases CD4+ T cell counts and decreases cellular activation levels, inhibits X4 viral growth. However, we show here that even in the simplest dual-strain framework, competition between R5 and X4 viruses often results in accelerated X4 emergence in response to CCR5 inhibition, further highlighting the potential danger of anti-CCR5 monotherapy in multi-strain HIV infection.

    Citation: Ariel D. Weinberger, Alan S. Perelson. Persistence and emergence of X4 virus in HIV infection[J]. Mathematical Biosciences and Engineering, 2011, 8(2): 605-626. doi: 10.3934/mbe.2011.8.605

    Related Papers:

    [1] Sophia Y. Rong, Ting Guo, J. Tyler Smith, Xia Wang . The role of cell-to-cell transmission in HIV infection: insights from a mathematical modeling approach. Mathematical Biosciences and Engineering, 2023, 20(7): 12093-12117. doi: 10.3934/mbe.2023538
    [2] Bing Li, Yuming Chen, Xuejuan Lu, Shengqiang Liu . A delayed HIV-1 model with virus waning term. Mathematical Biosciences and Engineering, 2016, 13(1): 135-157. doi: 10.3934/mbe.2016.13.135
    [3] Tinevimbo Shiri, Winston Garira, Senelani D. Musekwa . A two-strain HIV-1 mathematical model to assess the effects of chemotherapy on disease parameters. Mathematical Biosciences and Engineering, 2005, 2(4): 811-832. doi: 10.3934/mbe.2005.2.811
    [4] Damilola Olabode, Libin Rong, Xueying Wang . Stochastic investigation of HIV infection and the emergence of drug resistance. Mathematical Biosciences and Engineering, 2022, 19(2): 1174-1194. doi: 10.3934/mbe.2022054
    [5] Tae Jin Lee, Jose A. Vazquez, Arni S. R. Srinivasa Rao . Mathematical modeling of impact of eCD4-Ig molecule in control and management of HIV within a host. Mathematical Biosciences and Engineering, 2021, 18(5): 6887-6906. doi: 10.3934/mbe.2021342
    [6] Shengqiang Liu, Lin Wang . Global stability of an HIV-1 model with distributed intracellular delays and a combination therapy. Mathematical Biosciences and Engineering, 2010, 7(3): 675-685. doi: 10.3934/mbe.2010.7.675
    [7] Helong Liu, Xinyu Song . Stationary distribution and extinction of a stochastic HIV/AIDS model with nonlinear incidence rate. Mathematical Biosciences and Engineering, 2024, 21(1): 1650-1671. doi: 10.3934/mbe.2024072
    [8] Ting Guo, Zhipeng Qiu . The effects of CTL immune response on HIV infection model with potent therapy, latently infected cells and cell-to-cell viral transmission. Mathematical Biosciences and Engineering, 2019, 16(6): 6822-6841. doi: 10.3934/mbe.2019341
    [9] Vivek Sreejithkumar, Kia Ghods, Tharusha Bandara, Maia Martcheva, Necibe Tuncer . Modeling the interplay between albumin-globulin metabolism and HIV infection. Mathematical Biosciences and Engineering, 2023, 20(11): 19527-19552. doi: 10.3934/mbe.2023865
    [10] Cameron Browne . Immune response in virus model structured by cell infection-age. Mathematical Biosciences and Engineering, 2016, 13(5): 887-909. doi: 10.3934/mbe.2016022
  • Approximately 50% of late-stage HIV patients develop CXCR4-tropic (X4) virus in addition to CCR5-tropic (R5) virus. X4 emergence occurs with a sharp decline in CD4+ T cell counts and accelerated time to AIDS. Why this phenotypic switch to X4 occurs is not well understood. Previously, we used numerical simulations of a mathematical model to show that across much of parameter space a promising new class of antiretroviral treatments, CCR5 inhibitors, can accelerate X4 emergence and immunodeficiency. Here, we show that mathematical model to be a minimal activation-based HIV model that produces a spontaneous switch to X4 virus at a clinically-representative time point, while also matching in vivo data showing X4 and R5 coexisting and competing to infect memory CD4+ T cells. Our analysis shows that X4 avoids competitive exclusion from an initially fitter R5 virus due to X4v unique ability to productively infect nave CD4+ T cells. We further justify the generalized conditions under which this minimal model holds, implying that a phenotypic switch can even occur when the fraction of activated nave CD4+ T cells increases at a slower rate than the fraction of activated memory CD4+ T cells. We find that it is the ratio of the fractions of activated nave and memory CD4+ T cells that must increase above a threshold to produce a switch. This occurs as the concentration of CD4+ T cells drops beneath a threshold. Thus, highly active antiretroviral therapy (HAART), which increases CD4+ T cell counts and decreases cellular activation levels, inhibits X4 viral growth. However, we show here that even in the simplest dual-strain framework, competition between R5 and X4 viruses often results in accelerated X4 emergence in response to CCR5 inhibition, further highlighting the potential danger of anti-CCR5 monotherapy in multi-strain HIV infection.


  • This article has been cited by:

    1. Juan Wang, Zongxing Yang, Nan-Ping Wu, Jin Yang, Increased expression of BCL11B and its recruited chromatin remodeling factors during highly active antiretroviral therapy synergistically represses the transcription of human immunodeficiency virus type 1 and is associated with residual immune activation, 2020, 165, 0304-8608, 321, 10.1007/s00705-019-04475-8
    2. Jan Schmökel, Hui Li, Asma Shabir, Hangxing Yu, Matthias Geyer, Guido Silvestri, Donald L. Sodora, Beatrice H. Hahn, Frank Kirchhoff, Link between Primate Lentiviral Coreceptor Usage and Nef Function, 2013, 5, 22111247, 997, 10.1016/j.celrep.2013.10.028
    3. Joëlle Bader, Martin Däumer, Franziska Schöni-Affolter, Jürg Böni, Meri Gorgievski-Hrisoho, Gladys Martinetti, Alexander Thielen, Thomas Klimkait, Therapeutic Immune Recovery and Reduction of CXCR4-Tropic HIV-1, 2017, 64, 1058-4838, 295, 10.1093/cid/ciw737
    4. Fabrice Dumas, Evert Haanappel, Lipids in infectious diseases – The case of AIDS and tuberculosis, 2017, 1859, 00052736, 1636, 10.1016/j.bbamem.2017.05.007
    5. Zhangwen Ge, Yi Feng, Kang Li, Bowen Lv, Silvere D Zaongo, Jia Sun, Yanling Liang, Dan Liu, Hui Xing, Min Wei, Ping Ma, Yiming Shao, CRF01_AE and CRF01_AE Cluster 4 Are Associated With Poor Immune Recovery in Chinese Patients Under Combination Antiretroviral Therapy, 2020, 1058-4838, 10.1093/cid/ciaa380
    6. Jinliang Li, Jharna R. Das, Pingtao Tang, Zhe Han, Jyoti K. Jaiswal, Patricio E. Ray, Transmembrane TNF-αFacilitates HIV-1 Infection of Podocytes Cultured from Children with HIV-Associated Nephropathy, 2017, 28, 1046-6673, 862, 10.1681/ASN.2016050564
    7. Marilyn Lewis, Julie Mori, Jonathan Toma, Mike Mosley, Wei Huang, Paul Simpson, Roy Mansfield, Charles Craig, Elna van der Ryst, David L. Robertson, Jeannette M. Whitcomb, Mike Westby, Alan Landay, Clonal analysis of HIV-1 genotype and function associated with virologic failure in treatment-experienced persons receiving maraviroc: Results from the MOTIVATE phase 3 randomized, placebo-controlled trials, 2018, 13, 1932-6203, e0204099, 10.1371/journal.pone.0204099
    8. Antoine Chaillon, Sara Gianella, Simon Dellicour, Stephen A. Rawlings, Timothy E. Schlub, Michelli Faria De Oliveira, Caroline Ignacio, Magali Porrachia, Bram Vrancken, Davey M. Smith, HIV persists throughout deep tissues with repopulation from multiple anatomical sources, 2020, 130, 0021-9738, 1699, 10.1172/JCI134815
    9. Matteo Surdo, Emanuela Balestra, Patrizia Saccomandi, Fabiola Di Santo, Marco Montano, Domenico Di Carlo, Loredana Sarmati, Stefano Aquaro, Massimo Andreoni, Valentina Svicher, Carlo Federico Perno, Francesca Ceccherini-Silberstein, Michael Schindler, Inhibition of Dual/Mixed Tropic HIV-1 Isolates by CCR5-Inhibitors in Primary Lymphocytes and Macrophages, 2013, 8, 1932-6203, e68076, 10.1371/journal.pone.0068076
    10. J Bader, F Schöni-Affolter, J Böni, M Gorgievski-Hrisoho, G Martinetti, M Battegay, T Klimkait, Correlating HIV tropism with immunological response under combination antiretroviral therapy, 2016, 17, 14642662, 615, 10.1111/hiv.12365
    11. Olivia D. Council, Sarah B. Joseph, Evolution of Host Target Cell Specificity During HIV-1 Infection, 2018, 16, 1570162X, 13, 10.2174/1570162X16666171222105721
    12. Stanca M. Ciupe, Elissa J. Schwartz, Understanding virus–host dynamics following EIAV infection in SCID horses, 2014, 343, 00225193, 1, 10.1016/j.jtbi.2013.11.003
    13. Borislav Savkovic, Geoff Symonds, John M. Murray, Derya Unutmaz, Stochastic Model of In-Vivo X4 Emergence during HIV Infection: Implications for the CCR5 Inhibitor Maraviroc, 2012, 7, 1932-6203, e38755, 10.1371/journal.pone.0038755
    14. Guan-Han Li, Caroline Anderson, Laura Jaeger, Thao Do, Eugene O. Major, Avindra Nath, Cell-to-cell contact facilitates HIV transmission from lymphocytes to astrocytes via CXCR4, 2015, 29, 0269-9370, 755, 10.1097/QAD.0000000000000605
    15. Khadijeh Khanaliha, Farah Bokharaei-Salim, Tahereh Donyavi, Javid Sadri Nahand, Arezoo Marjani, Sogol Jamshidi, Alireza Khatami, Maryam Moghaddas, Maryam Esghaei, Atousa Fakhim, Evaluation of CCR5-Δ32 mutation and HIV-1 surveillance drug-resistance mutations in peripheral blood mononuclear cells of long-term non progressors of HIV-1-infected individuals, 2022, 17, 1746-0794, 429, 10.2217/fvl-2021-0028
    16. Barbara Weiser, Binshan Shi, Kimdar Kemal, Harold Burger, Howard Minkoff, Qiuhu Shi, Wei Gao, Esther Robison, Susan Holman, Tamara Schroeder, Alissa Gormley, Kathryn Anastos, Christina Ramirez, Long-term antiretroviral therapy mitigates mortality and morbidity independent of HIV tropism: 18 years follow-up in a women's cohort, 2022, 36, 0269-9370, 1979, 10.1097/QAD.0000000000003337
    17. Maria S. Serna-Arbeláez, Valentina García-Cárcamo, Daniel S. Rincón-Tabares, Diego Guerra, Vanessa Loaiza-Cano, Marlen Martinez-Gutierrez, Jaime A. Pereañez, Manuel Pastrana-Restrepo, Elkin Galeano, Wildeman Zapata, In Vitro and In Silico Antiviral Activity of Di-Halogenated Compounds Derived from L-Tyrosine against Human Immunodeficiency Virus 1 (HIV-1), 2023, 45, 1467-3045, 8173, 10.3390/cimb45100516
    18. Manukumar Honnayakanahalli Marichannegowda, Michelle Zemil, Lindsay Wieczorek, Eric Sanders-Buell, Meera Bose, Anne Marie O'Sullivan, David King, Leilani Francisco, Felisa Diaz-Mendez, Saini Setua, Nicolas Chomont, Nittaya Phanuphak, Jintanat Ananworanich, Denise Hsu, Sandhya Vasan, Nelson L. Michael, Leigh Anne Eller, Sodsai Tovanabutra, Yutaka Tagaya, Merlin L. Robb, Victoria R. Polonis, Hongshuo Song, Tracking coreceptor switch of the transmitted/founder HIV-1 identifies co-evolution of HIV-1 antigenicity, coreceptor usage and CD4 subset targeting: the RV217 acute infection cohort study, 2023, 98, 23523964, 104867, 10.1016/j.ebiom.2023.104867
    19. Natacha Faivre, Christel Verollet, Fabrice Dumas, The chemokine receptor CCR5: multi-faceted hook for HIV-1, 2024, 21, 1742-4690, 10.1186/s12977-024-00634-1
    20. Nayuta Seto, Takahiko Fukuchi, Mamiyo Kawakami, Mami Nagashima, Kenji Sadamasu, Shuji Hatakeyama, Seronegative HIV-1 infection in a Japanese man presenting with Pneumocystis pneumonia: Analysis of long-term antibody response and literature review, 2024, 1341321X, 10.1016/j.jiac.2024.02.005
    21. Michael Rameen Moezpoor, Mario Stevenson, Help or Hinder: Protein Host Factors That Impact HIV-1 Replication, 2024, 16, 1999-4915, 1281, 10.3390/v16081281
    22. Kunjing Geng, Wenchao Wei, Sisi Chen, Haoxi Shi, Weiguang Fan, Genetic Characteristics of the Env Regions in HIV-1-Infected Subjects in Baoding City, Hebei Province, China, 2025, 22, 1570162X, 409, 10.2174/011570162X321660241127102018
  • Reader Comments
  • © 2011 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(3282) PDF downloads(494) Cited by(22)

Article outline

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog